NeuroBo Pharmaceuticals(NRBO) - 2019 Q3 - Quarterly Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q (Mark One) Commission file number 001-37809 Gemphire Therapeutics Inc. (Exact name of Registrant as specified in its charter) Delaware 47‑2389984 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) P.O. Box 130235, Ann Arbor, MI 48113 (Address of principal executive offices) (Zip Code) (734) 245‑1700 Non-accelerated filer ☐ Smaller reporting company ☒ Emerging growth ...